668
Views
70
CrossRef citations to date
0
Altmetric
Research Article

Anthrax Toxin

&
Pages 167-200 | Published online: 29 Sep 2008

REFERENCES

  • Pasteur, L., De attenuation des virus et de leur retour a la virulence, CR Acad Sci. Agric. Bulg., 92, 429, 1881.
  • Metchnikoff, E., Immunity in Infective Diseases, Cambridge University Press, London, 1905.
  • Turnbull, P.C.B., Anthrax vaccines: past, present and future, Vaccine, 9, 533, 1992.
  • Stephen, J., Anthrax toxin. In: Pharmacology of Bacterial Toxins. Dorner, F.and Drews, J., Eds., Oxford, Pregamon Press, 1986, 381.
  • Hanna, P.C., Acosta, D., and Collier, R.J., On the role of macrophages in anthrax, Proc. Natl. Acad. Sci. USA, 90, 10198, 1993.
  • Pienaar, U de V, Epidemiology of anthrax in wild animals and the control of anthrax epizootics in the Kruger National Park, South Africa, Fed. Proc., 26, 1496, 1967.
  • Ebedes, H., Anthrax epizootics in Etosha National Park, Madoqua, 10, 99, 1976.
  • Manchee, R.J. and Broster, M.G., Bacillus anthracis on Guinard island, Nature, 294, 254, 1981.
  • Manchee, R.J. and Broster, M.G., Formaldehyde solution effectively inactivates spores of Bacillus anthracis on the Scottish island of Guinard, Appl. Environ. Microbiol., 60, 4167, 1994.
  • Meselsohn, M., Guillemin, J., Hugh-Jones, M., Langmuir, A., Papova, I., Schelokov, A., and Yompolskaya, O., The Sverdlosk anthrax outbreak of 1979, Science, 266, 1202, 1994.
  • Friedlander, A.M., Bhatnagar, R., Leppla, S.H. and Singh, Y., Characterization of mac-rophage sensitivity and resistance to anthrax lethal toxin, Infect. Immun., 61, 245, 1993.
  • Ballard, J.D., Collier, R.J., and Starnbach, M.N., Anthrax toxin mediated delivery of cytotoxic T cell epitope in vivo, Proc. Natl. Acad. Sci.USA, 93, 12531, 1996.
  • Goletz, T.J., Klimpel, K.R., Leppla, S.H., Keith, J.M., and Berzofsky, J.A., Delivery of antigens to the MHC class I pathway using bacterial toxins, Hum. Immunol., 54, 129, 1997.
  • Goletz, T.J., Klimpel, K.R., Arora, N., Leppla, S.H., Keith, J.M., and Berzofsky, J.A., Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein, Proc. Natl. Acad. Sci. (USA) 94, 12059, 1997.
  • Sirard, J.C., Mock, M., and Fouet, A., The three Bacillus anthracis toxin genes are coor-dinately regulated by bicarbonate and temperature, J. Bacteriol., 176, 5188, 1994.
  • Varughese, M., Teixeira, A.V., Nicholls, P.J., Keith, J.M., and Leppla, S.H., Inter-nalization of a Bacillus anthracis protective antigen-c-myc antibodies, Mol. Med., 4, 87, 1998.
  • Ballard, J.D., Doling, A.M., Beauregard, K., Collier, R.J., and Starnbach, M.N., Anthrax toxin-mediated delivery in vivo and in vitro of a cytotoxic T-lymphocyte epitope from ovalbumin, Infect. Immun., 66, 615, 1998.
  • Davis, J.C.A., A major epidemic of anthrax in Zimbabwe, Central. Afr.J.Med., 28, 291(Part1); 29, 8 (Part 2); 31, 176 (Part 3).
  • Abramova, F.A., Grinberg, I.M., Yampol-skaya, O.V., and Walker, D.H., Pathology of inhalation anthrax in 42 cases from Sverdlosk outbreak in 1979, Proc. Natl. Acad. Sci. USA, 90, 2294, 1993.
  • Brachman, P.S., Gold, H., Plotkin, S.A., Fekety, F.R., Werrin, M., and Ingraham, N.R., Field evaluation of human anthrax vaccine, Am. J. Public Health, 52, 632, 1962.
  • Brachman, P.S., Anthrax, Ann NY Acad. Sci., 174, 577, 1970.
  • Turnbull, P.C.B., Anthrax. In: Principles of Bacteriology, Virology and immunity, 8th ed., Vol. 3, Smith, G.R. and Easman, C.S.F., Eds., 1990, 366.
  • Cherkasskiy, B.L., A national register of historic and contemporary anthrax foci, 1998. In: Abstract Book Pg.2, III International Conference on Anthrax, Plymouth, UK.
  • Kaufmann, A.F., Observations on the ocurrence of anthrax as related to soil type and rainfall, Salisbury Medical Bulletin, 68(Suppl.), 16, 1990.
  • Joshi, D.D., Anthrax situation in south asian countries in general and Nepal in particular 1997, In: Abstract Book Pg 91, IIIrd International Conference on Anthrax, held at University of Plymouth, 1998, Plymouth, U.K.
  • Meynell, E.and Meynell, G.G., The roles of serum and carbondioxide in capsule formation by Bacillus anthracis, J. Gen. Microbiol., 34, 153, 1964.
  • Record, B.R. and Wallis, R.G., Physiochemical examination of polyglutamic acid from Bacillus anthracis grown in vivo, Biochem. J., 63, 443, 1956.
  • Zwartouw, H.T. and Smith, H., Polyglutamic acid from Bacillus anthracis grown in vivo: structure and aggressin activity, Biochem. J., 63, 437, 1956.
  • Gerhardt, P., Cytology of Bacillus anthracis, Fed. Proc., 26, 1504, 1967.
  • Holt, S.C. and Leadbetter, S.R., Comparative ultrastructure of selected aerobic spore-forming bacteria: a freeze-etching study, Bacteriol. Rev., 33, 346, 1969.
  • Sleytr, U.B. and Messner, P., Crystalline surface layers on bacteria, Ann. Rev. Microbiol., 377, 311, 1983.
  • Fouet, A., Mesnage, S., Tosi-Couture, E., Gounon, P., and Mock, M., Bacillus anthracis S-layer, FEMS Microbiol. lett., 20, 55, 1997.
  • Fouet, A., Mesnage, S., Tosi-Couture, E., Gounon, P., and Mock, M., Bacillus anthracis surface: capsule and S-layer, J. Appl. Microbiol., 87, 251, 1999.
  • Lupas, A., Engelhardt, H., Peters, J., Santarius, U., Volker, S., and Baumeiser, W., Domain structure of the Acetogenium kivui surface revealed by electron crystallography and sequence analysis, J. Bacteriol., 176, 1224, 1994.
  • Mesnage, S., Tosi-Couture, E., and Fouet, A., Production and cell surface anchoring of functional fusions between the SLH motifs of the Bacillus anthracis S-layer proteins and the Bacillus subtilis levansurase, Mol. Microbiol., 31, 927, 1999.
  • Van Ness, G.B., Ecology of anthrax, Science, 172, 1303, 1971.
  • Taylor, M.J., Kennedy, G.H., and Blundell, G.P., Experimental in the rat.I.The rapid increase of natural resistance observed in young hists, Am.J.Pathol., 38, 469, 1961.
  • Heyworth, B., Anthrax in the Gambia: a epi-demiological study, Br. Med.J., 4, 79, 1975.
  • Jena, G.P., Intestinal anthrax in man: a case report, Central Afr.J.Med., 26, 253, 1980.
  • Turnbull, P.C.B. and Kramer, J.M., Bacillus. In: Manual of Clinical Microbiology, 6th ed., ASM Press, 1995.
  • Cromartie, W.J., Bloom, W.L., and Watson, D.W., Studies on infection with Bacillus anthracis; a histopathological study of skin lesions produced by Bacillus anthracis in susceptible and resistant animal species, J. Infect. Dis., 80, 1, 1947.
  • Smith, H.and Keppie, J., Observations on experimental anthrax: demonstration of a specific lethal factor produced in vivo by Bacillus anthracis, Nature, 173, 869, 1954.
  • Smith, H., Keppie, J., and Stanely, J.L., The chemical basis of virulence of Bacillus anthracis.V.The specific toxin produced by B. anthracis in vivo, Br.J.Exp. Pathol., 36, 460, 1955.
  • Smith, H., Tempest, D.W., Stanley, J.L., Harris-Smith, P.W., and Gallop, R.C., The chemical basis of virulence of B. anthracis. VII Two components of anthrax toxin: their relationship to known immunising aggressins, Br.J.Expt. Pathol., 37, 263, 1956.
  • Pile, J.C., Malone, J.D., Eitzen, E.M., and Friedlander, A.M., Anthrax as a potential biologic warfare agent, Arch. Intern. Med., 158, 429, 1998.
  • Bail, O.and Sterne, M., Anthrax In: Infectious Diseases of Animals, Stableforth, A.W., and Galloway, I.A., Eds., Butterworths Scientific Publications, London, 1959, 22.
  • Fish, D.C. and Lincoln, R.E., In vivo produced anthrax toxin, J. Bacteriol., 95, 919, 1968.
  • Lincoln, R.E. and Fish, D.C., Anthrax toxin. In: Microbiol Toxins, Montie, T.C., Kadis, S., and Ajl, S.J., Eds., 3 New York, Academic Press, 1970, 361.
  • Smith, H.and Stoner, H.B., Anthrax toxic complex, Fed. Proc., 26, 1554, 1967.
  • Pezard, C., Berche, P., and Mock, M., Contribution of individual toxin components to virulence of Bacillus anthracis, Infect. Immun., 59, 3472, 1991.
  • Mikesell, O.P., Ivins, B.E., Ristroph, J.D., and Dreir, T.M., Evidence for plasmid mediated toxin production in B.anthracis, Infect. Immun., 39, 371, 1983.
  • Green, B.D., Battisti, L., Koehler, T.M., Thorne, C.B., and Ivins, B.E., Demonstration of a capsule plasmid in B.anthracis, Infect. Immun., 49, 291, 1985.
  • Uchida, I., Sekizaki, T., Hasimoto, K., and Terkado, N., Association of the encapsulation of B. anthracis with a 60 megadalton plasmid, J. Gen. Microbiol., 131, 363, 1985.
  • Kaspar, R.L. and Robertson, D.L., Purification and physical analysis of Bacillus anthracis plasmid pXO1 and pXO2, Biochem. Biophys. Res. Commun., 149, 362, 1987.
  • Robertson, D.L., Bragg, T.S., Simpson, S., Casper, R., Xie, W., and Tippetts, M.T., Mapping and characterisation of Bacillus anthracis plasmids pXO1 and pXO2. Salisbury Medical Bulletin, 68 (Spec. Suppl.) 55, 1990.
  • Koehler, T.M., Dai, Z., and Yarbray, M.K., Regulation of the B.anthracis protective anti gen gene: CO2 and a trans acting element activate transcription from one of two promoters, J. Bacteriol., 176, 586, 1994.
  • Mock, M., La-Bruyere, E., Glaser, P., Danchin, A., and Ullman, A., Cloning and expression of the calmodulin sensitive B. anthracis adenylate cyclase in E. coli, Gene, 64, 277, 1988.
  • Robertson, D.L. and Leppla, S.H., Molecular cloning and expression in E.coli of the lethal factor gene of B.anthracis, Gene, 44, 71, 1986.
  • Robertson, D.L., Tippetts, M.T., and Leppla, S.H., Nucleotide sequence of the B.anthracis edema factor gene: a calmodulin-dependent adenylate cyclase, Gene, 73, 363, 1988.
  • Uchida, I., Hornung, J.M., Thorne, C.B., Klimpel, K.R., and Leppla, S.H., Cloning and characterization of a gene whose product is a transactivator of anthrax toxin synthesis, J. Bacteriol. 175, 5329, 1993.
  • Vodkin, M.H. and Leppla, S.H., Cloning of the protective antigen gene of B. anthracis, Cell, 34, 693, 1983.
  • Leppla, S.H., Production and purification of anthrax toxin. In: Methods in Enzymology, Harshman, S., Ed., Academic Press, San Diego, 1988, 165, 103.
  • Makino, S., Sasakawa, C., Uchida, I., Terakoda, N., and Yoshikawa, M., Cloning and CO2 dependant expression of the genetic region for encapsulation from Bacillus anthracis, Mol. Microbiol., 2, 371, 1988.
  • Makino, S., Uchida, I., Terakoda, N., Sasakawa, C., and Yoshikawa, M., Molecular characteization and protien analysis of the cap region, which is essential for encapsulation in Bacillus anthracis, J. Bacteriol., 171, 722, 1989.
  • Uchida, I., Hashimoto, K., Makino, S., Sasakawa, C., Yoshikawa, M., and Terakado, N., Restriction map of a capsule plasmid of Bacillus anthracis, Plasmid, 18, 178, 1987.
  • Miller, J.F., Mekalanos, J.J., and Falkow, S., Coordinate regulation and sensory transduction in the control of bacterial virulence, Science., 243, 916, 1989.
  • Bartkus, J.M. and Leppla, S.H., Transcrip-tional regulation of the protective antigen of Bacillus anthracis, Infect. Immun., 57, 2295, 1989.
  • Dai, Z., Sirard, J.C., Mock, M., and Koehler, T.M., The atxA gene product activates transcription of the anthrax toxin genes and is essential for virulence, Mol. Microbiol., 16, 1171, 1995.
  • Hoffmaster, A.R. and Koehler, T.M., The anthrax toxin activator gene atx A is associated with CO2 enhanced non-toxin gene expression in B. anthracis, Infect. Immun., 65, 3091, 1997.
  • Vietri, N.J., Marrero, R., Hoover, T.A., and Welkos, S.L., Identification and Characterization of a trans activator involved in the regulation of encapsulation by B.anthracis, Gene, 152, 1, 1995.
  • Uchida, I., Makino, S., Sekizaki, T., and Terakado, N., Cross-talk to the genes for Bacillus anthracis capsule synthesis by atxA, the gene encoding the trans-activator of anthrax toxin synthesis, Mol. Microbiol., 23, 1229, 1997.
  • Leppla, S.H., Anthrax toxins. In: Bacterial Toxins and Virulence Factors in Disease. Handbook of Natural Toxins, Moss, J., Iglewski, B., VaughanM., and TuA.T., Eds., Marcel Dekker, New York, 1995, 8, 543.
  • Hoffmaster, A.R. and Koehler, T.M., Autogenous regulation of the Bacillus anthracis pag operon, J. Bacteriol., 181, 4485, 1999.
  • Cataldi, A., Fouet, A., and Mock, M., Regulation of pag gene expression in Bacillus anthracis: use of a pag-lacZ transcriptional fusion, FEMS Microbiol. Lett., 98, 89, 1992.
  • Dai, Z.and Koehler, T.M., Regulation of Anthrax Toxin Activator Gene (atxA) Expression in Bacillus anthracis: temperature, Not CO2/Bicarbonate, affects Atx A Synthesis, Infect. Immun., 65, 2576, 1997.
  • Gladstone, G.P., Immunity to anthrax. Protective antigen present in cell free filterates. Br.J.Exp. Pathol., 27, 349, 1946.
  • Welkos, S.L., Lowe, J.R., Eden-McCutchan, F., Vodkin, M., and Leppla, S.H., Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis, Gene, 69, 287, 1988.
  • Leppla, S.H., The anthrax toxin complex. In: Sourcebook of Bacterial Protein Toxins, Alouf, J.E. and Freer, J.H., Eds. Academic Press, London, 1991, 277.
  • Quinn, P.C., Singh, Y., Klimpel, R.K., and Leppla, S.H., Functional mapping of anthrax toxin lethal factor by in frame insertion mu-tagenesis, J. Biol. Chem., 266, 20124, 1991.
  • Cataldi, A., Labruyere, F., and Mock, M., Construction and characterization of a protective antigen deficient Bacillus anthracis strain, Mol. Microbiol., 4, 1111, 1990.
  • Perelle, S., Gibert, M., Boquet, P., and Popoff, M.R., Charaterization of Clostridium perfuringes iota toxin and expression in E. coli, Infect. Immun., 61, 5147, 1993.
  • Warren, G., Novel pesticidal proteins and strains. World intellectual property organization. Patent application WO 96/10083, 1996.
  • Petosa, C., Collier, R.J., Klimpel, K.R., Leppla, S.H., and Liddington, R.C., Crystal structure of anthrax toxin protective antigen, Nature, 385, 833, 1997.
  • Stephen, J.and Pietrowski, R.A., Bacterial toxins. In: Aspects of Microbiology, 1986, 2nd Am. Soc. Microbiol, Washington, DC.
  • Novak, J., Stein, M.P., Little, S.F., Leppla, S.H., and Friedlander, A.M., Functional characterization of protease treated Bacillus anthracis protective antigen, J. Biol. Chem., 267, 17186, 1992.
  • Singh, Y., Klimpel, K.R., Arora, N., Sharma, M., and Leppla, S.H., Chymot-rypsin sensitive site FFD (315) in anthrax toxin PA is required for translation of lethal factor, J. Biol. Chem., 269, 29039, 1994.
  • Blaustein, R.O., Koehler, T.M., Collier, R.J., and Finkelstein, A., Anthrax toxin: channel forming activity of protective antigen in planer phospholipid bilayers, Proc. Natl. Acad. Sci. USA, 86, 2209, 1989.
  • Singh, Y., Chaudhary, V.K., and Leppla, S.H., A deleted variant of B. anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo, J. Biol. Chem., 264, 19103, 1989.
  • Molloy, S.S., Bresnahan, P.A., Leppla, S.H., Klimpel, K.R., and Thomas, G., Human furin is a Calcium dependent Serine Endoprotease that recognizes the sequence R-X-X-R and efficiently cleaves anthrax toxin protective antigen, J. Biol. Chem., 267, 16396, 1992.
  • Friedlander, A.M., Macrophages are sensitive to anthrax toxin through an acid dependent process, J. Biol. Chem., 261, 7123, 1986.
  • Gordon, V.M., Leppla, S.H. and Hewlett, F.L., Inhibitors of receptor mediated endocy-tosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin, Infect. Immun., 56, 1066, 1988.
  • Milne, J.C., Blanke, S.R., Hanna, P.C., Wall, J.S., and Collier, R.J., Protective antigen binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino or carboxy terminus, Mol. Microbiol., 15, 661, 1995.
  • Blaustein, R.O., LeaE.J., and Finkelstein, A., Voltage dependent block of anthrax toxin channels in planer phospholipid bilayer membranes by symmetric tetraalkylammonium ions: single channel analysis, J. Gen. Physiol., 96, 921, 1990.
  • Koehler, T.M. and Collier, R.J., Anthrax toxin protective antigen: low pH induced hy-drophobicity and channel formation in lipo-somes, Mol. Microbiol., 5, 1501, 1991.
  • Gordon, V.M., Young, W.W., Lechler, S.M., Gray, M.C., Leppla, S.H. and Hewlett, E.L., Adenylate cyclase toxins from B. anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cells, J. Biol. Chem., 264, 14792, 1989.
  • Milne, J.C. and Collier, R.J., pH dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen, Mol Microbiol., 10, 647, 1993.
  • Ojcius, D.M. and Young, J.D., Cytolytic pore forming proteins and peptides: is there a common structural motif? Trends Biochem. Sci., 16, 225, 1991.
  • Milne, J.C., Furlong, D., Hanna, P.C., Wall, J.S., and Collier, R.J., Anthrax protective antigen forms oligomers during intoxication of mammalian cells, J. Biol. Chem., 269, 20607, 1994.
  • Singh, Y., Klimpel, K.R., Goel, S., Swain, P.K., and Leppla, S.H., Oligomerization of the anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells, Infect. Immun., 67, 1853, 1999.
  • Finkelstein, A., The channel formed in planer lipid bilayers by the protective antigen component of anthrax toxin, Toxicology, 87, 29, 1994.
  • Zhao, J., Milne, J.C., and Collier, R.J., Effect of anthrax toxins lethal factor on ion channels formed by protective antigen, J. Biol. Chem., 270, 18626, 1995.
  • Singh, Y., Klimpel, K.R., Quinn, C.P., Chaudhary, V.K., and Leppla, S.H., The carboxy terminal end of protective antigen is required for receptor binding and anthrax toxin activity, J. Biol. Chem., 266, 15493, 1991.
  • Radha, C., Salotra, P., Bhat, R., and Bhatnagar, R., Thermostabilization of protective antigen — the binding component of anthrax lethal toxin, J. Biotechnol., 50, 235, 1996.
  • Batra, S., Gupta, P., Chauhan, V., Singh, A., and Bhatnagar, R., Trp 346 and Leu 352 residues in protective antigen are required for the expression of anthrax lethal toxin activity, Biochem Biophys Res Commun., 281, 186, 2001.
  • Ezzel, J.W., Ivins, B.E., and Leppla, S.H., Immunoelectrophoretic analysis, toxicity and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin, Infect. Immun., 45, 761, 1984.
  • Bhatnagar, R., Singh, Y., Leppla, S.H., and Friedlander, A.M., Calcium is required for the expression of anthrax lethal toxin activity in the macrophage like cell line J774A.1, Infect. Immun., 57, 2107, 1989.
  • Bragg, T.S. and Robertson, D.L., Nucle-otide sequence and analysis of the lethal factor gene (lef) from Bacillus anthracis, Gene, 81, 45, 1989.
  • Arora, N., Klimpel, K.R., Singh, Y., and Leppla, S.H., Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotox-ins which are translocated to the cytosol of mammalian cells, J. Biol. Chem, 267, 15542, 1992.
  • Arora, N.and Leppla, S.H., Residues 1-254 of anthrax toxin lethal factor sufficient to cause cellular uptake of fused polypeptides, J. Biol. Chem., 268, 3334, 1993.
  • Arora, N.and Leppla, S.H., Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells, Infect. Immun., 62, 4955, 1994.
  • Arora, N., Site-directed mutagenesis of his-tidine residues in anthrax toxin lethal factor binding domain reduces toxicity, Mol. Cell. Biochem., 177, 7, 1997.
  • Klimpel, K.R., Arora, N., and Leppla, S.H., Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity, Mol. Microbiol., 13, 1093, 1994.
  • Hanna P.C., Anthrax pathogenesis and host response, Curr. Topics Microbiol. Immunol., 225, 13, 1998.
  • Kochi, A.K., Schiavo, G., Mock, M., and Motecucco, C., Zinc content of the Bacillus anthracis lethal factor, FEMS Microb. Lett., 124, 343, 1994.
  • Menard, A., Papini, E., Mock, M., and Montecucco, C., The cytotoxic activity of Bacillus anthracis lethal factor by leucotrine A4 hydrolase and metallopeptidase inhibitors, Biochem. J., 320, 687, 1996.
  • Hanna, P.C., Kochi, S., and Collier, R.J., Biochemical and physiological changes induced by anthrax lethal toxin in J774A.1 macrophage like cells, Mol. Biol. Cell, 3, 1269, 1992.
  • Bhatnagar, R.and Friedlander, A.M., Protein synthesis is required for expression of anthrax lethal toxin cytotoxicity, Infect. Immun., 62, 2958, 1994.
  • Bhatnagar, R., Ahuja, N., Goila, R., Batra, S., Waheed, S.M., and Gupta, P., Activation of phospholipase C and protein kinase C is required for expression of anthrax toxin cytotoxicity in J774A.1 cells, Cellular Signalling, 11, 111, 1999.
  • Fawthrop, D.J., Boobis, A.R., and Davies, D.S., Mechanism of cell death, Arch Toxicol., 65, 437, 1991.
  • Hanna, P.C., Kruskal, B.A., Allen, R., Ezekowitz, B., Bloom, B.R., and Collier, R.J., Role of macrophage oxidative burst in the action of anthrax lethal toxin, Mol. Med., 1, 7, 1994.
  • Menard, A., Altendorf, K., Breves, D., Mock, M., and Montecucco, C., The vacu-olar ATPase pump is required for the cyto-toxicity of Bacillus anthracis lethal toxin, FEBS Letters, 161, 1996.
  • Hammond, S.E. and Hanna, P.C., Lethal factor active site mutations affect catalytic activity in vitro, Infect. Immun., 62, 2374, 1998.
  • Duesbery, N.S., Craig, P.W., Leppla, S.H., Gordon, V.M., Klimpel, K.R., Copeland, T.D., Ahn, N.G., Oskarsson, M.K., Fukasawa, K., Paull, K.D., and Wonde, G.F.V., Proteolytic Inactvation of MAP-Kinase-Kinase by anthrax lethal factor, Science, 280, 734, 1998.
  • Vitale, G., Pellizzari, R., Recchi, C., Napolitani, G., Mock, M., and Montecucco, C., Anthrax lethal factor cleaves the N-termi-nus of MAPKKs and induces Tyrosine/Threo-nine phosphorylation of MAPKs in cultured macrophages, Biochem. Biophysics Res. Commun., 248, 706, 1998.
  • Lewis, T.S., Shapiro, P.S., and Ahn, N.G., Signal transduction through MAP kinase cas cades. In: Advances in cancer research, Vande Woude, G.F. and Klein, G., Eds., Academic Press, San Diego, 1998, 74,49.
  • Masui, Y.and Markert, C.L., Cytoplasmic control of nuclear behaviour during meiotic maturation of frog oocytes, J. Exp. Zool., 177, 129, 1971.
  • Pellizzari, R., Guidi-Rontani, C., Vitale, G., Mock, M., and Montecucco, C., Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNg-induced release of NO and TNF?, FEBS Lett., 462, 199, 1999.
  • Hoffmeyer, A., Grosse-Wilde, A., Flory, E., Neufeld, E., Kunz, M., Rapp, U.R., and Ludwig, S., Different mitogen activated protein kinase signalling pathways cooperate to regulate tumor necrosis factor alpha gene expression in T lymphocytes, J. Biol. Chem., 274, 4319, 1999.
  • Beyaert, R., Cuenda, A., Vanden Berghe, W., Plaisance, S., Lee, J.C., Haegman, G., Cohen, P., and Fiers, W., The p38/RK mito-gen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor, EMBO J., 15, 1914, 1996.
  • Lin, C.G., Kao, Y.T., Liu, W.T., Huang, H.H., Chen, K.C., Wang, T.M., and Lin, H.C., Cytotoxic effects of anthrax lethal toxin on macrophage-like cell line J774A.1, Curr. Microbiol., 33, 224, 1996.
  • Tang, G.and Leppla, S.H., Proteosome activity is required for anthrax lethal toxin to kill macrophages, Infect. Immun., 67, 3055, 1999.
  • Gupta, P., Singh, A., Chauhan, V., and Bhatnagar, R., Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis, Biochem Biophys Res Commun., 280, 158, 2001.
  • Escuyer, V., Dflot, E., Sezer, O., Danchin, A., and Mock, M., Structural homology between virulence associated bacterial adeny-late cyclases, Gene, 71, 293, 1988.
  • Leppla, S.H., Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cAMP conc. in eukaryotic cells, Proc. Natl. Acad. Sci. USA., 79, 3162, 1982.
  • Pezard, C., Duflot, E., and Mock, M., Construction of Bacillus anthracis mutant strains producing a single toxin component, J. Gen. Microbiol., 139, 2459, 1993.
  • Confer, D.L. and Eaton, J.W., Phagocytic impotence caused by the invasive bacterial adenylate cyclase, Science, 217, 948, 1982.
  • O’Brien, J.and Friedlander, A.M., Effects of anthrax toxin components on human neu-trophils, Infect. Immun., 47, 306, 1985.
  • Wade, B., Wright, G.G., Hewlett, E., Leppla, S.H., and Mandell, G.L., Anthrax toxin components stimulate chemotaxis of human poly-morphonuclear neutrophils, Proc. Soc. Exp. Biol. Med., 179, 159, 1985.
  • Wright, G.G. and Mandell, G.L., Anthrax toxin blocks priming of neutrophils by li-popolysaccharide and by muramyl dipeptide, J. Exp. Med., 164, 1700, 1986.
  • Hoover, D.L., Friedlander, A.M., Rogers, L.C., Yoon, I.K., Warren, R.L., and Cross, A.L., Anthrax edema toxin differentialy regulates lipopolysaccharide induced monocyte production of tumour necrosis factor alpha and interleukin 6 by increasing intracellular cyclic AMP, Infect.Immun., 62, 4432, 1994.
  • Stanley, J.L. and Smith, H., Purification of Factor I and recognition of a third factor of anthrax toxin, J. Gen. Microbiol., 26, 49, 1961.
  • Xia, Z.and Storm, D.R., A-type ATP binding consensus sequences are critical for the catalytic activity of the calmodulin-sensitive adenlyl cyclase from B. anthracis, J. Biol. Chem., 265, 6517, 1990.
  • Munier, H., Blanco, F.J., Precheur, B., Diesis, E., Nieto, J.L., Craescu, C.T., and Barzu, O., Characterization of a synthetic calmodulin binding peptide derived from Bacillus anthracis adenylate cyclase, J. Biol. Chem., 268, 1695, 1993.
  • Keppie, J., Harris-Smith, P.W., and Smith, H., The chemical basis of virulence of Bacillus anthracis IX Its aggressins and their mode of action, Br.J.Exp. Pathol., 44, 446, 1963.
  • Ivins, B.E. and Welkos, S.L., Recent advances in the development of an improved human anthrax vaccine, Eur.J.Epidemol., 4, 12, 1988.
  • Escuyer, V.and Collier, R.J., Anthrax protective antigen interacts with a specific receptor on the surface of CHO-K1 cells, Infect. Immun., 59, 3381, 1991.
  • Klimpel, K.R., Molloy, S.S., Thomas, G., and Leppla, S.H., Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin, Proc. Natl. Acad. Sci. USA, 89, 10277, 1992.
  • Molloy, S.S., Thomas, L., Vanslykr, J.K., Stenberg, P.E., and Thomas, G., Intracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling to the cell surface, EMBO, 13, 18, 1994.
  • Koehler, T.M., Blaustein, R.O., Finkelstein, A., and Collier, R.J., Interaction of Protective antigen with membranes, Salisbury Medical Bulletin, 68(Spec. Suppl.), 45, 1990.
  • Almond, B.D. and Eidels, L., The cytoplas-mic domain of the diphtheria toxin receptor (HB-EGF precursor) is not required for receptor-mediated endocytosis, J. Biol. Chem., 269, 26635, 1994.
  • Wesche, J., Elliot, J.L., Falnes, P.O., Olsnes, S., and Collier, R.J., Characterization of membrane translocation by anthrax protective antigen, Biochemistry, 37, 15737, 1998.
  • Yamaizumi, Y., Mekada, E., Uchida, T., and Okada, Y., One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell, Cell, 15, 245, 1978.
  • Puziss, M., Manning, L.C., Lynch, L.W., Barclay, E., Abelow, I.and Wright, G.G., Large-scale production of protective antigen of B. anthracis anaerobic cultures, Appl. Microbiol., 11, 330, 1963.
  • Ristroph, J.D. and Ivins, B.E., Production of Bacillus anthracis antigens in a new defined culture media, Infect. Immun., 39, 483, 1983.
  • Haines, B.W., Klein, F., and Lincoln, R.E., Quantitation assay for crude anthrax toxins, J. Bacteriol., 89, 74, 1965.
  • Stanley, J.L., Sargeant, K., and Smith, H., Purifications of Factors I and II of the anthrax toxin produced in vivo, J. Gen. Microbiol., 22, 206, 1960.
  • Harris-Smith, P.W., Smith, H., and Keppie, J., Production in vitro of the toxin of B. anthracis previosly recognized in vivo, J. Gen. Microbiol., 19, 91, 1958.
  • Thorne, C.B., Molnar, D.M., and Strange, R.E., Production of toxin in vitro by Bacillusanthracis and its separation into two components, J. Bacteriol., 79, 450, 1960.
  • Quinn, P.C., Shone, C.C., Turnbull, T.B., and. Melling, J., Purification of anthrax toxin components by high performance anion-ex-change, gel filtration and hydrophobic interaction chromatography, Biochem. J., 252, 753, 1988.
  • Larson, D.K., Calton, G.J., Little, S.F., Leppla, S.H., and Burnett, J.W., Separation of three exotoxic factors of B. anthracis by sequential immunoadsorbent chromatography, Toxicon, 26, 913, 1988.
  • Ivins, B.E. and Welkos, S.L., Cloning and expression of the B.anthracis protective antigen gene in B. subtilis, Infect. Immun., 54, 537, 1986.
  • Kawamura, F.and Doi, R.H., Construction of a Bacillus subtilis double mutant deficient in extracellular alkaline and neutral proteases, J. Bacteriol., 160, 442, 1984.
  • Wu, Z.R., Development of a novel Bacillus subtilis cloning system employing its neutral protease as screen marker, Gene, 106, 103, 1991.
  • Stark, W., Pauptii, R.A., Wilson, K.S., The structure of neutral protease from Bacillus cereus at 0.2 nm resolution, Eur.J.Biochem., 207, 781, 1992.
  • Farchaus, J.W., Ribot, W.J., Jendrek, S., and Little, S.F., Fermentation, Purification and Characterization of Protective Antigen from a Recombinant, Avirulent Strain of B. anthracis, Appl. Env. Microbiol., 64, 982, 1998.
  • Iacono-Connors, L.C., Schmaljohn, C.S., and Dalrymple, J.M., Expression of Bacillus anthracis protective antigen by baculovirus and vaccinia virus recombinants, Infect. Immun., 1990, 58, 366, 1990.
  • Gupta, P., Waheed, S.M., and Bhatnagar, R., Expression and purification of the recom-binant Protective antigen of B. anthracis, Protein Expression and Purification, 16, 369, 1999.
  • Gupta, P., Batra, S., Chopra, A.P., Singh, Y., and Bhatnagar, R., Expression and purification of the recombinant lethal factor ofBacillus anthracis, Infect Immun., 66, 862, 1998.
  • Park, S.and Leppla, S.H., Optimized production and purification of Bacillus anthracis lethal factor, Pr. Exp. Pur., 18, 293, 2000.
  • Stepanov, A.V., Marinin, L.I., Pomerantsev, A.P., and Staritsin, N.A., Development of novel vaccines against anthrax in man, J. Biotechnol., 44, 155, 1996.
  • Sterne, M., Distribution and economic importance of anthrax, Fed. Proc., 126, 1493, 1967.
  • Sterne, M., The use of anthrax vaccine prepared from avirulent (uncapsulated) variants of B.anthracis, OnderstepoortJ.Vet. Sci. Anim. Ind., 13, 307, 1939.
  • Sterne, M., The effects of different carbondioxide concentrations on the growth of virulent anthrax strains. Pathogenicity and immunity tests on guinea-pigs and sheep with anthrax variants derived from virulent strains, OnderstepoortJ.vet. Sci. An. Ind., 9, 49, 1937.
  • Hambleton, P., Craman, J.A., and Melling, J., Anthrax: the disease in relation to vaccines, Vaccine, 2, 125, 1984.
  • Puziss, M.and Wright, G.G., Studies on immunity in anthrax.X.Gel-adsorbed protective antigen for immunization of man, J. Bacteriol., 85, 230, 1962.
  • Turnbull, P.C.B., Thoroughly modern anthrax, Ales. Hyg. Trop. Dis., 61, 1, 1986.
  • Belton, F.C. and Strange, R.E., Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and methods of production, Br.J.Exp. Pathol., 35, 144, 1954.
  • Henderson, D.W., Peacock, S., and Belton, F.C., Observations on the prophylaxis of experimental pulmonary anthrax in the monkey, J. Hyg., 54, 28, 1956.
  • Klein, F., Hodges, D.R., Mahlandt, B.G., Jones, W.I., Haines, B.W., and Lincoln, R.E., Anthrax toxin: causative agent in the death of Rhesus monkeys, Science, 138, 1331, 1962.
  • Little, S.F., Novak, N.M., Lowe, J.R., Leppla, S.H., Singh, Y., Klimpel, K.R., and Friedlander, A.M., Characterization of lethal factor binding and cell receptor binding domains of protective antigen of B. anthracis using monoclonal antibodies, Microbiology, 142, 707, 1996.
  • Little, S.F., Leppla, S.H., and Cora, E., Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis, Infect. Immun., 58, 1606, 1990.
  • Little, S.F., Leppla, S.H. and Cora, E., Production and Characterization of monoclonal antibodies to the protective antigen component of B. anthracis, Infect. Immun., 56, 1807, 1988.
  • Little, S.F., Leppla, S.H., Burnett, J.W., and Friedlander, A.M., Structure function analysis of Bacillus anthracis edema factor by using monoclonal antibodies, Biochem. Biophys. Res. Commun., 199, 676, 1994.
  • Ivins, B.E., Pitt, M.L.M., Fellows, P.F., Gibbs, P.H., and Friedlander, A.M., Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against against an aerosol Bacillus anthracis spore challenge in guinea pigs, Vaccine, 13, 1779, 1995.
  • Pezard, C., Weber, M., Sirard, J., Berche, P., and Mock, M., Protective immunity induced by B. anthracis toxin deficient strains, Infect. Immun., 63, 1369, 1995.
  • Ivins, B.E., Welkos, S.L., Little, S.F., Crumrine, M.H., and Nelson, G.O., Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants, Infect. Immun., 60, 662, 1992.
  • Turnbull, P.C.B., Quinn, C.P., Hewron, R., Stockbridge, M.C., and Melling, J., Protection conferred by microbially supplemented UK and purified PA vaccines, Salisbury Medical Bulletin, 68(Suppl.), 89, 1990.
  • Jones, M.N., Beedham, R.J., Turnbull, P.C.b., Fitzgeorge, R.B., and Manchee, R.J., Efficacy of the UK human anthrax vaccine in guinea pigs against aerosolized spores of Bacillus anthracis, Salisbury Medical Bulletin, 87(Suppl.), 123, 1995.
  • Ribi, E., Cantrell, J., and Yakayama, K., A new immunomodulator with potential clinical applications: monophosphoryl lipid A, a detoxified endotoxin, Immunol. Newslett., 6, 33, 1985.
  • Ivins, B.E., Welkos, S.L., Knudson, G.B., and Little, S.F., Immunization against anthrax with aromatic compound dependent (Aro) mutants of Bacillus anthracis and with the recombinant strains of Bacillus subtilis that produce anthrax protective antigen, Infect. Immun., 58, 303, 1990.
  • Coulson, N.M., Fulop, M., and Titball, R.W., Bacillus anthracis protective antigen expressed in Salmonella typhimurium SL3261, affords protection against anthrax spore challenge, Vaccine, 12, 1395, 1994.
  • Zegers, D., Stap, H.V., Dura, E.V., Kluter, E., and Shaw, M., Expression of the Protective antigen of Bacillus anthracis by Lactobacillus strains: Towards the development of an oral vaccine against anthrax. In: Abstract book Pg. 35 III International Conference on Anthrax at University of Plymouth, Plymouth, U.K.
  • Mi-Li Gu, Stephen, H., and Klinman, D.M., Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen, Vaccine, 17, 340, 1999.
  • Williamson, E.D., Beedham, R.J., Bennet, A.M., Perkins, S.D., Miller, J., and Baillie, L.W.J., Presentation of protective antigen to the mouse immune system: immune sequelae, J. Appl. Microbiol., 87, 315, 1999.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.